Monistat-3 Combination Pack en es it fr

Monistat-3 Combination Pack Brand names, Monistat-3 Combination Pack Analogs

Monistat-3 Combination Pack Brand Names Mixture

  • No information avaliable

Monistat-3 Combination Pack Chemical_Formula

C27H34N2O7

Monistat-3 Combination Pack RX_link

http://www.rxlist.com/cgi/generic2/moexip.htm

Monistat-3 Combination Pack fda sheet

Monistat-3 Combination Pack msds (material safety sheet)

Monistat-3 Combination Pack Synthesis Reference

No information avaliable

Monistat-3 Combination Pack Molecular Weight

498.568 g/mol

Monistat-3 Combination Pack Melting Point

No information avaliable

Monistat-3 Combination Pack H2O Solubility

Soluble (about 10% weight-to-volume) in distilled water at room temperature as HCl salt.

Monistat-3 Combination Pack State

Solid

Monistat-3 Combination Pack LogP

3.31

Monistat-3 Combination Pack Dosage Forms

Tablets (scored, coated, containing 7.5 mg or 15 mg of moexipril hydrochloride for oral administration)

Monistat-3 Combination Pack Indication

For treatment of patients with hypertension.

Monistat-3 Combination Pack Pharmacology

Moexipril is a non-sulfhydryl containing precursor of the active angiotensin-converting enzyme (ACE) inhibitor moexiprilat. It is used to treat high blood pressure (hypertension). It works by relaxing blood vessels, causing them to widen. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems.

Monistat-3 Combination Pack Absorption

Moexipril is incompletely absorbed, with bioavailability as moexiprilat of about 13% compared to intravenous (I.V.) moexipril (both measuring the metabolite moexiprilat), and is markedly affected by food, which reduces Cmax and AUC by about 70% and 40% respectively after the ingestion of a low-fat breakfast or by 80% and 50% respectively after the ingestion of a high-fat breakfast.

Monistat-3 Combination Pack side effects and Toxicity

Human overdoses of moexipril have not been reported. In case reports of overdoses with other ACE inhibitors, hypotension has been the principal adverse effect noted. Single oral doses of 2 g/kg moexipril were associated with significant lethality in mice. Rats, however, tolerated single oral doses of up to 3 g/kg.

Monistat-3 Combination Pack Patient Information

Monistat-3 Combination Pack Organisms Affected

Humans and other mammals